Related Experiment Video

Updated: May 27, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

EphrinA5 suppresses colon cancer development by negatively regulating epidermal growth factor receptor stability

Tong-Hong Wang1, Junn-Liang Chang, Jar-Yi Ho

  • 1Tissue Bank, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan.

The FEBS Journal
|November 15, 2011
PubMed

Insights

EphrinA5 suppresses colon cancer by degrading EGFR. Lower EphrinA5 levels correlate with advanced cancer, suggesting its therapeutic potential against colon cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Colon cancer is a leading global malignancy requiring understanding of its carcinogenesis mechanisms.
  • EphrinA5 is a potential tumor suppressor in glioma, but its role in colon cancer is largely unknown.

Purpose of the Study:

  • To investigate the biological significance of EphrinA5 in colon cancer.
  • To determine the relationship between EphrinA5, epidermal growth factor receptor (EGFR), and colon cancer progression.

Main Methods:

  • Immunohistochemistry on tissue microarrays to assess EphrinA5 and EGFR expression in colon cancer vs. normal tissues.
  • Gain-of-function and loss-of-function studies in SW480 and WiDr colon cancer cell lines.
  • Analysis of EphrinA5's effect on cell proliferation, survival, migration, and EGFR regulation.

Main Results:

  • EphrinA5 mRNA and protein levels were significantly reduced in colon cancer tissues compared to normal tissues.
  • Reduced EphrinA5 expression correlated negatively with tumor differentiation and clinical stage.
  • EphrinA5 suppressed colon cancer cell proliferation, migration, and chemoresistance by promoting c-Cbl-mediated EGFR ubiquitination and degradation.

Conclusions:

  • EphrinA5 inhibits colon cancer progression through c-Cbl-mediated degradation of EGFR.
  • This study reveals a novel mechanism for targeting EGFR in colon cancer therapy.

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.